A new CAR T-cell therapy developed by the UCL Cancer Institute shows very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL) in a trial led by Professor Persis Amrolia and Dr Sara Ghorashian (both UCL GOS Institute of Child Health).
Read: FT, More: UCL News
Close
